Brief: Amedisys Says CEO Chris Gerard Will Leave Company Effective November 17, 2022
18/11/2022 24:08
Nov 17 (Reuters) - Amedisys Inc AMED.O :
* AMEDISYS CONFIRMS FULL YEAR GUIDANCE
* PRESIDENT AND CHIEF EXECUTIVE OFFICER, CHRIS GERARD, WILL
LEAVE
THE COMPANY EFFECTIVE NOVEMBER 17, 2022
* PAUL KUSSEROW, CHAIR OF BOARD OF DIRECTORS WILL TAKE OVER
AS CEO
UNTIL A NEW CHIEF EXECUTIVE OFFICER IS IDENTIFIED
Source text for Eikon: ID:nPn7tQkZla
Further company coverage: AMED.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Amedisys
See all newsBrief: Amedisys Inc And Unitedhealth Agree To Proposed Final Judgment
UnitedHealth to sell off 164 locations to settle US challenge to Amedisys deal (updated)
US Justice Dept. says broad divestitures required to resolve challenge to Unitedhealth’s acquisition of Amedisys
Amedisys Inc reports results for the quarter ended June 30 - Earnings Summary
Amedisys' Q2 adjusted EPS beats estimates